Portfolio Holdings Detail for ISIN IE00BDZVHG35
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
| ETF Ticker | BTEE(USD) LSE |
| ETF Ticker | BTEE.L(GBP) LSE |
Holdings detail for IMCR
| Stock Name | Immunocore Holdings Ltd |
| Ticker | IMCR(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US45258D1054 |
| LEI | 213800IUE3DFS84BVN18 |
Show aggregate IMCR holdings
News associated with IMCR
- Analysts Set Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) PT at $56.89
- Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Get Free Report) have earned a consensus recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating […] - 2025-09-15 02:30:24
- Immunocore (NASDAQ:IMCR) Coverage Initiated at Jefferies Financial Group
- Equities research analysts at Jefferies Financial Group initiated coverage on shares of Immunocore (NASDAQ:IMCR – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “buy” rating and a $48.00 price target on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 47.19% […] - 2025-08-27 02:08:52
- Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Rating of “Moderate Buy” by Analysts
- Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a […] - 2025-08-18 05:10:58
- XTX Topco Ltd Decreases Stock Position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR)
- XTX Topco Ltd lessened its position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Free Report) by 3.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,192 shares of the company’s stock after selling 704 shares during the quarter. […] - 2025-08-07 05:00:52
- Oppenheimer Asset Management Inc. Takes $225,000 Position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR)
- Oppenheimer Asset Management Inc. bought a new position in shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor bought 7,574 shares of the company’s stock, valued at approximately $225,000. Several other hedge funds and other institutional investors have also modified their holdings of […] - 2025-07-01 04:50:55
- GAMMA Investing LLC Increases Stock Position in Immunocore Holdings plc (NASDAQ:IMCR)
- GAMMA Investing LLC increased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 3,318.1% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 19,107 shares of the company’s stock after buying an additional 18,548 shares during the quarter. GAMMA Investing LLC’s holdings in Immunocore were worth $5,670,000 as of its […] - 2025-06-10 04:38:58
- HC Wainwright Reiterates “Buy” Rating for Immunocore (NASDAQ:IMCR)
- Immunocore (NASDAQ:IMCR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $100.00 price target on the stock. HC Wainwright’s price target indicates a potential upside of 158.80% from the stock’s previous close. A number of other […] - 2025-06-04 02:51:03
- Immunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Squarepoint Ops LLC
- Squarepoint Ops LLC lowered its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 2.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 69,954 shares of the company’s stock after selling 2,114 shares during the quarter. Squarepoint Ops LLC owned about […] - 2025-05-29 05:18:57
- Deutsche Bank Aktiengesellschaft Initiates Coverage on Immunocore (NASDAQ:IMCR)
- Deutsche Bank Aktiengesellschaft assumed coverage on shares of Immunocore (NASDAQ:IMCR – Get Free Report) in a note issued to investors on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $65.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s target price indicates a potential upside of 106.41% from the company’s previous close. Other […] - 2025-05-29 02:31:00
- Millennium Management LLC Cuts Stake in Immunocore Holdings plc (NASDAQ:IMCR)
- Millennium Management LLC reduced its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 15.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 573,362 shares of the company’s stock after selling 103,269 shares during the period. Millennium Management […] - 2025-05-22 05:01:00
- BNP Paribas Financial Markets Makes New Investment in Immunocore Holdings plc (NASDAQ:IMCR)
- BNP Paribas Financial Markets bought a new position in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 193,115 shares of the company’s stock, valued at approximately $5,697,000. BNP Paribas Financial Markets owned 0.39% of Immunocore as […] - 2025-05-14 06:10:56
- Immunocore Holdings plc (NASDAQ:IMCR) Receives $58.13 Consensus PT from Brokerages
- Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have earned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to […] - 2025-05-13 02:44:54
- Barclays PLC Buys 19,663 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
- Barclays PLC increased its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 2,044.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 20,625 shares of the company’s stock after purchasing an additional 19,663 shares during the quarter. Barclays PLC’s holdings in Immunocore were […] - 2025-05-08 04:36:44
- Marshall Wace LLP Lowers Stock Holdings in Immunocore Holdings plc (NASDAQ:IMCR)
- Marshall Wace LLP lessened its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 85.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 28,610 shares of the company’s stock after selling 170,833 shares during the quarter. Marshall Wace […] - 2025-05-01 05:43:01
- Immunocore Holdings plc (NASDAQ:IMCR) Stake Boosted by Geode Capital Management LLC
- Geode Capital Management LLC grew its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 1.2% during the 4th quarter, HoldingsChannel reports. The fund owned 35,492 shares of the company’s stock after acquiring an additional 420 shares during the period. Geode Capital Management LLC’s holdings in Immunocore were worth $1,047,000 as of […] - 2025-05-01 04:32:55
- Renaissance Technologies LLC Sells 179,630 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
- Renaissance Technologies LLC decreased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 65.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,570 shares of the company’s stock after selling 179,630 shares during the period. Renaissance Technologies LLC owned […] - 2025-04-25 05:17:01
- Brokerages Set Immunocore Holdings plc (NASDAQ:IMCR) Price Target at $63.73
- Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have issued a buy recommendation on the company. […] - 2025-04-18 02:28:59
- Immunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Orion Portfolio Solutions LLC
- Orion Portfolio Solutions LLC lessened its position in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 37.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,017 shares of the company’s stock after selling 7,675 shares during the period. Orion Portfolio […] - 2025-04-09 05:02:51
- Financial Contrast: Immunocore (NASDAQ:IMCR) vs. Creative Medical Technology (NASDAQ:CELZ)
- Creative Medical Technology (NASDAQ:CELZ – Get Free Report) and Immunocore (NASDAQ:IMCR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Earnings and Valuation This table compares Creative […] - 2025-04-01 02:57:01
- Immunocore Holdings plc (NASDAQ:IMCR) Receives Consensus Recommendation of “Moderate Buy” from Analysts
- Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have given a buy recommendation to the […] - 2025-03-26 04:56:59
- Principal Financial Group Inc. Sells 43,461 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
- Principal Financial Group Inc. reduced its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 8.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 502,857 shares of the company’s stock after selling 43,461 shares during the period. Principal Financial […] - 2025-02-27 07:06:54
- Immunocore Holdings plc (NASDAQ:IMCR) Receives Average Rating of “Moderate Buy” from Analysts
- Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have received an average recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating […] - 2025-02-04 06:36:58
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) IMCR holdings
| Date | Number of IMCR Shares Held | Base Market Value of IMCR Shares | Local Market Value of IMCR Shares | Change in IMCR Shares Held | Change in IMCR Base Value | Current Price per IMCR Share Held | Previous Price per IMCR Share Held |
|---|
| 2025-12-03 (Wednesday) | 28,585 | USD 1,082,800 | USD 1,082,800 | 0 | USD 48,881 | USD 37.88 | USD 36.17 |
| 2025-12-02 (Tuesday) | 28,585 | USD 1,033,919 | USD 1,033,919 | 1,020 | USD -2,249 | USD 36.17 | USD 37.59 |
| 2025-12-01 (Monday) | 27,565 | USD 1,036,168 | USD 1,036,168 | 0 | USD -52,650 | USD 37.59 | USD 39.5 |
| 2025-11-28 (Friday) | 27,565 | USD 1,088,818 | USD 1,088,818 | 68 | USD -14,637 | USD 39.5 | USD 40.13 |
| 2025-11-27 (Thursday) | 27,497 | USD 1,103,455 | USD 1,103,455 | 0 | USD 0 | USD 40.13 | USD 40.13 |
| 2025-11-26 (Wednesday) | 27,497 | USD 1,103,455 | USD 1,103,455 | 204 | USD 15,283 | USD 40.13 | USD 39.87 |
| 2025-11-25 (Tuesday) | 27,293 | USD 1,088,172 | USD 1,088,172 | 340 | USD 45,360 | USD 39.87 | USD 38.69 |
| 2025-11-24 (Monday) | 26,953 | USD 1,042,812 | USD 1,042,812 | 68 | USD -15,113 | USD 38.69 | USD 39.35 |
| 2025-11-21 (Friday) | 26,885 | USD 1,057,925 | USD 1,057,925 | 0 | USD 9,141 | USD 39.35 | USD 39.01 |
| 2025-11-20 (Thursday) | 26,885 | USD 1,048,784 | USD 1,048,784 | -272 | USD -834 | USD 39.01 | USD 38.65 |
| 2025-11-19 (Wednesday) | 27,157 | USD 1,049,618 | USD 1,049,618 | 68 | USD 18,611 | USD 38.65 | USD 38.06 |
| 2025-11-18 (Tuesday) | 27,089 | USD 1,031,007 | USD 1,031,007 | 408 | USD 55,283 | USD 38.06 | USD 36.57 |
| 2025-11-17 (Monday) | 26,681 | USD 975,724 | USD 975,724 | 136 | USD 21,431 | USD 36.57 | USD 35.95 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of IMCR by Blackrock for IE00BDZVHG35
Show aggregate share trades of IMCR| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-12-02 | BUY | 1,020 | 37.815 | 35.805 | 36.006 | USD 36,726 | 32.11 |
| 2025-11-28 | BUY | 68 | 40.530 | 39.130 | 39.270 | USD 2,670 | 32.04 |
| 2025-11-26 | BUY | 204 | 40.490 | 39.540 | 39.635 | USD 8,086 | 31.96 |
| 2025-11-26 | BUY | 204 | 40.490 | 39.540 | 39.635 | USD 8,086 | 31.96 |
| 2025-11-25 | BUY | 340 | 40.205 | 38.760 | 38.904 | USD 13,228 | 31.92 |
| 2025-11-24 | BUY | 68 | 40.115 | 38.475 | 38.639 | USD 2,627 | 31.89 |
| 2025-11-20 | SELL | -272 | 40.060 | 38.705 | 38.841 | USD -10,565 | 31.81 Loss of -1,912 on sale |
| 2025-11-19 | BUY | 68 | 39.070 | 37.640 | 37.783 | USD 2,569 | 31.77 |
| 2025-11-18 | BUY | 408 | 38.165 | 36.150 | 36.352 | USD 14,831 | 31.74 |
| 2025-11-17 | BUY | 136 | 37.390 | 35.860 | 36.013 | USD 4,898 | 31.72 |
| 2025-11-14 | BUY | 68 | 36.690 | 34.800 | 34.989 | USD 2,379 | 31.69 |
| 2025-11-12 | BUY | 68 | 35.640 | 34.960 | 35.028 | USD 2,382 | 31.66 |
| 2025-11-10 | BUY | 67 | 35.480 | 33.940 | 34.094 | USD 2,284 | 31.62 |
| 2025-11-06 | BUY | 68 | 31.750 | 30.500 | 30.625 | USD 2,083 | 31.61 |
| 2025-11-04 | BUY | 68 | 32.503 | 31.330 | 31.447 | USD 2,138 | 31.61 |
| 2025-10-30 | BUY | 340 | 33.500 | 32.085 | 32.226 | USD 10,957 | 31.60 |
| 2025-10-29 | BUY | 136 | 32.850 | 33.855 | 33.754 | USD 4,591 | 31.59 |
| 2025-10-22 | SELL | -272 | 32.510 | 33.770 | 33.644 | USD -9,151 | 31.55 Loss of -569 on sale |
| 2025-10-20 | BUY | 136 | 33.940 | 33.990 | 33.985 | USD 4,622 | 31.53 |
| 2025-10-17 | BUY | 339 | 33.560 | 34.220 | 34.154 | USD 11,578 | 31.51 |
| 2025-10-15 | BUY | 536 | 34.390 | 34.510 | 34.498 | USD 18,491 | 31.50 |
| 2025-10-03 | BUY | 455 | 34.210 | 35.500 | 35.371 | USD 16,094 | 31.48 |
| 2025-10-02 | BUY | 65 | 35.290 | 37.000 | 36.829 | USD 2,394 | 31.46 |
| 2025-09-30 | BUY | 130 | 36.330 | 36.720 | 36.681 | USD 4,769 | 31.40 |
| 2025-09-26 | BUY | 130 | 34.020 | 35.003 | 34.905 | USD 4,538 | 31.36 |
| 2025-09-25 | BUY | 130 | 34.080 | 34.340 | 34.314 | USD 4,461 | 31.35 |
| 2025-09-18 | BUY | 68 | 33.415 | 34.415 | 34.315 | USD 2,333 | 31.33 |
| 2025-09-17 | BUY | 204 | 33.415 | 34.470 | 34.365 | USD 7,010 | 31.32 |
| 2025-07-17 | SELL | -134 | 36.210 | 36.360 | 36.345 | USD -4,870 | 31.21 Loss of -689 on sale |
| 2025-07-11 | SELL | -544 | 35.020 | 35.280 | 35.254 | USD -19,178 | 31.10 Loss of -2,261 on sale |
| 2025-07-02 | BUY | 3,740 | 32.750 | 33.950 | 33.830 | USD 126,524 | 31.02 |
| 2025-06-25 | BUY | 136 | 32.010 | 32.350 | 32.316 | USD 4,395 | 31.00 |
| 2025-06-13 | BUY | 765 | 34.680 | 36.010 | 35.877 | USD 27,446 | 30.93 |
| 2025-06-11 | BUY | 130 | 35.560 | 37.100 | 36.946 | USD 4,803 | 30.86 |
| 2025-06-10 | BUY | 130 | 35.930 | 37.560 | 37.397 | USD 4,862 | 30.82 |
| 2025-06-04 | SELL | -65 | 37.700 | 39.330 | 39.167 | USD -2,546 | 30.62 Loss of -556 on sale |
| 2025-04-23 | BUY | 65 | 29.800 | 30.850 | 30.745 | USD 1,998 | 30.45 |
| 2025-04-10 | SELL | -520 | 25.820 | 26.290 | 26.243 | USD -13,646 | 30.72 Profit of 2,327 on sale |
| 2025-04-08 | SELL | -65 | 24.530 | 27.670 | 27.356 | USD -1,778 | 30.84 Profit of 227 on sale |
| 2025-04-07 | SELL | -65 | 26.280 | 27.195 | 27.103 | USD -1,762 | 30.90 Profit of 246 on sale |
| 2025-04-04 | SELL | -325 | 27.260 | 28.555 | 28.426 | USD -9,238 | 30.94 Profit of 816 on sale |
| 2025-04-01 | BUY | 272 | 28.630 | 29.670 | 29.566 | USD 8,042 | 30.98 |
| 2025-03-31 | SELL | -195 | 29.670 | 29.840 | 29.823 | USD -5,815 | 31.00 Profit of 229 on sale |
| 2025-03-21 | BUY | 884 | 29.810 | 30.970 | 30.854 | USD 27,275 | 31.11 |
| 2025-03-14 | SELL | -1,008 | 28.800 | 29.840 | 29.736 | USD -29,974 | 31.23 Profit of 1,511 on sale |
| 2025-03-07 | SELL | -126 | 29.800 | 31.200 | 31.060 | USD -3,914 | 31.41 Profit of 44 on sale |
| 2025-03-04 | SELL | -63 | 29.250 | 29.570 | 29.538 | USD -1,861 | 31.47 Profit of 122 on sale |
| 2025-02-25 | BUY | 126 | 29.210 | 30.960 | 30.785 | USD 3,879 | 31.64 |
| 2025-02-19 | SELL | -63 | 29.770 | 29.930 | 29.914 | USD -1,885 | 31.77 Profit of 117 on sale |
| 2025-02-13 | BUY | 186 | 29.740 | 30.050 | 30.019 | USD 5,584 | 31.95 |
| 2025-02-12 | BUY | 62 | 29.560 | 29.785 | 29.762 | USD 1,845 | 32.00 |
| 2025-02-11 | BUY | 248 | 28.205 | 30.120 | 29.929 | USD 7,422 | 32.07 |
| 2024-12-30 | SELL | -1,784 | 29.030 | 29.370 | 29.336 | USD -52,335 | 32.47 Profit of 5,594 on sale |
| 2024-11-18 | SELL | -1,005 | 31.050 | 31.730 | 31.662 | USD -31,820 | 32.80 Profit of 1,146 on sale |
| 2024-11-08 | SELL | -67 | 34.690 | 34.710 | 34.708 | USD -2,325 | 32.60 Loss of -141 on sale |
| 2024-10-21 | SELL | -67 | 33.310 | 34.620 | 34.489 | USD -2,311 | 0.00 Loss of -2,311 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of IMCR
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 15,894 | 0 | 38,023 | 41.8% |
| 2025-09-18 | 52,118 | 0 | 130,116 | 40.1% |
| 2025-09-17 | 127,316 | 106 | 336,166 | 37.9% |
| 2025-09-16 | 22,172 | 0 | 60,022 | 36.9% |
| 2025-09-15 | 30,923 | 0 | 57,072 | 54.2% |
| 2025-09-12 | 64,477 | 10,613 | 92,753 | 69.5% |
| 2025-09-11 | 44,734 | 7,540 | 73,113 | 61.2% |
| 2025-09-10 | 81,268 | 14,616 | 144,419 | 56.3% |
| 2025-09-09 | 43,822 | 0 | 115,260 | 38.0% |
| 2025-09-08 | 57,101 | 100 | 123,990 | 46.1% |
| 2025-09-05 | 64,334 | 0 | 309,443 | 20.8% |
| 2025-09-04 | 111,884 | 0 | 199,053 | 56.2% |
| 2025-09-03 | 182,260 | 7,100 | 246,636 | 73.9% |
| 2025-09-02 | 45,964 | 0 | 82,634 | 55.6% |
| 2025-08-29 | 41,259 | 0 | 64,534 | 63.9% |
| 2025-08-28 | 31,249 | 0 | 93,586 | 33.4% |
| 2025-08-27 | 33,751 | 0 | 76,487 | 44.1% |
| 2025-08-26 | 32,058 | 0 | 70,614 | 45.4% |
| 2025-08-25 | 32,403 | 0 | 84,037 | 38.6% |
| 2025-08-22 | 52,872 | 0 | 149,172 | 35.4% |
| 2025-08-21 | 51,854 | 0 | 227,606 | 22.8% |
| 2025-08-20 | 71,830 | 3,700 | 252,162 | 28.5% |
| 2025-08-19 | 40,306 | 0 | 101,416 | 39.7% |
| 2025-08-18 | 23,909 | 0 | 80,115 | 29.8% |
| 2025-08-15 | 27,295 | 0 | 107,899 | 25.3% |
| 2025-08-14 | 69,783 | 0 | 201,280 | 34.7% |
| 2025-08-13 | 51,653 | 0 | 170,858 | 30.2% |
| 2025-08-12 | 86,991 | 0 | 215,476 | 40.4% |
| 2025-08-11 | 97,408 | 0 | 151,749 | 64.2% |
| 2025-08-08 | 90,560 | 0 | 201,913 | 44.9% |
| 2025-08-07 | 146,985 | 0 | 268,466 | 54.7% |
| 2025-08-06 | 255,247 | 482 | 325,754 | 78.4% |
| 2025-08-05 | 27,088 | 3 | 57,687 | 47.0% |
| 2025-08-04 | 51,053 | 0 | 79,772 | 64.0% |
| 2025-08-01 | 185,630 | 0 | 271,547 | 68.4% |
| 2025-07-31 | 59,312 | 0 | 115,736 | 51.2% |
| 2025-07-30 | 46,707 | 0 | 163,165 | 28.6% |
| 2025-07-29 | 90,149 | 50 | 310,305 | 29.1% |
| 2025-07-28 | 30,648 | 0 | 78,815 | 38.9% |
| 2025-07-25 | 47,095 | 315 | 117,716 | 40.0% |
| 2025-07-24 | 18,700 | 18 | 50,453 | 37.1% |
| 2025-07-23 | 67,613 | 0 | 306,229 | 22.1% |
| 2025-07-22 | 49,560 | 0 | 159,351 | 31.1% |
| 2025-07-21 | 41,418 | 0 | 89,109 | 46.5% |
| 2025-07-18 | 42,373 | 2,608 | 105,641 | 40.1% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy